What causes the enhancement of activity of factor VIIa by tissue factor?

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 12, 2006, Pages 2726-2729

  Colina, C M ^a   Venkateswarlu, D ^b   Duke, R ^a,c   Perera, L ^a,c   Pedersen, L G ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

ARTICLE; COMPARATIVE STUDY; COMPLEX FORMATION; CRYSTAL STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY; X RAY CRYSTALLOGRAPHY;

CATALYTIC DOMAIN; COMPUTER SIMULATION; ENZYME ACTIVATION; FACTOR VIIA; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; SOFTWARE; THROMBOPLASTIN;

EID: 33751042724     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02222.x     Document Type: Article

References (19)

1. Ruf W. The interaction of activated VII with tissue factor: Insight into the mechanism of cofactor-mediated activation of activated factor VII. Blood Coagul. Fibrinolysis 1998; 9 (Suppl.1): S73-8.
2. Bon VJJ, Bertina RM. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood coagulation factor X by activated factor VII. Biochemistry J 1990; 265: 327-36.
3. Persson E, Bak H, Ostergaard A, Olsen OH. Augmented intrinsic activity of factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement. Biochem J 2004; 379: 497-503.
4. Perera L, Darden TA, Pedersen LG. Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association. Biophys J 1999; 77: 99-113.
5. Perera L, Darden TA, Pedersen LG. Predicted solution structure of zymogen human coagulation factor FVII. J Comput Chem 2002; 23: 35-47.
6. Jin JP, Perera L, Stafford D, Pedersen L. Four loops of the catalytic domain of factor VIIa mediate the effect of the first EGF-like domain substitution on the Factor VIIa catalytic activity. J Mol Biol 2001; 307: 1503-17.
7. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys 1995; 103: 8577-93.
8. Case DA, Darden TA, Cheatham III TE, Simmerling CL, Wang J, Duke RE, Luo R, Merz KM, Wang B, Pearlman DA, Crowley M, Brozell S, Tsui V, Gohlke H, Mongan J, Hornak JV, Cui G, Beroza P, Schafmeister C, Caldwell JW, Ross WS, Kollman PA. AMBER 8. San Francisco: University of California, 2004.
9. Banner DW, D'Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380: 41-46.
10. Muller YA, Utsch MH, de Vos AM. The crystal structure of the extracellular domain of human tissue factor refined to 1.7 angstrom resolution. J Mol Biol 1996; 256: 144-59
11. Higashi S, Nishimura H, Aita K, Iwanaga S. Identification of regions of bovine factor VII essential for binding to tissue factor. J Biol Chem 1994; 269; 18891-8.
12. Pike ACW, Brzozowski AM, Roberts SM, Olsen OH, Persson E. Structure of human factor VIIa and its implications for the triggering of blood coagulation. Proc Natl Acad Sci USA 1999; 96: 8925-30.
13. Sichler K, Banner DW, D'Arcy A, Hopfner KP, Huber R, Bode W, Kresse GB, Kopetzki E, Brandstetter H. Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions. J Mol Biol 2002; 322: 591-603.
14. Eigenbrot C, Kirchofer D, Dennis MS, Santell L, Lazarus RA, Stamos J, Ultsch MH. The factor VII zymogen structure reveals reregistration of beta strands during activation. Structure 2001; 9: 627-36.
15. Petrovan RJ, Ruf W. Role of zymogenicity-determining residues of coagulation factor VII/VIIa in cofactor interaction and macromolecular substrate recognition. Biochemistry 2002; 41: 9302-9.
16. McCallum CD, Su BX, Neuenschwander PF, Morrissey JH, Johnson AE. Tissue factor positions and maintains the factor VIIa active site far above the membrane surface even in the absence of the factor VIIa Gla domain - a fluorescence resonance energy transfer study. J Biol Chem 1997; 272: 30160-6.
17. Fromovich-Amit Y, Zivelin A, Rosenberg N, Landau M, Rosa JP, Seligshohn U. Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation. Blood Coagul Fibrinolysis 2005; 16: 369-74.
18. Dickinson CD, Kelly CR, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci USA 1996; 93: 14379-84.
19. Waxman E, Laws WR, Laue TM, Nemerson Y, Ross JBA. Human Factor-VIIa and its complex with soluble tissue factor - evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. Biochemistry 1993; 32: 3005-12.